Total medical devices industry M&A deals worth $21.21bn were announced in North America in January 2021, led by OptumInsight’s $13bn acquisition of Change Healthcare, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 224.8% over the previous month of $6.53bn and a rise of 304.8% when compared with the last 12-month average of $5.24bn.
North America held a 91.19% share of the global medical devices industry M&A deal value that totalled $23.26bn in January 2021. With a 91.19% share and deals worth $21.21bn, the US was the top country in North America’s M&A deal value across medical devices industry.
In terms of M&A deal activity, North America recorded 26 deals during January 2021, marking a decrease of 23.53% over the previous month and a rise of 18.18% over the 12-month average. The US recorded 25 deals during the month.
North America medical devices industry M&A deals in January 2021: Top deals
The top five medical devices industry M&A deals accounted for 94.3% of the overall value during January 2021.
The combined value of the top five medical devices deals stood at $20.01bn, against the overall value of $21.21bn recorded for the month.
The top five medical devices industry M&A deals of January 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition of Cantel Medical by Steris
3) Boston Scientific’s $1.23bn acquisition of Preventice
4) The $635m acquisition of Capsule Technologies by Koninklijke Philips
5) Thermo Fisher Scientific’s acquisition of Mesa Biotech for $550m.
